Market revenue in 2023 | USD 1.4 million |
Market revenue in 2030 | USD 2.7 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Forceps |
Fastest growing segment | Forceps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Forceps, Accessories |
Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 71.43% in 2023. Horizon Databook has segmented the Australia endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
In Australia, the implementation of favorable initiatives by the government and rising incidence of cardiovascular diseases are the major factors expected to promote market growth over the forecast period.
For instance, in 2019, Heart Week was celebrated in Australia from 28 April to 4 May, in which, healthcare professionals generated awareness among the Australian population regarding heart health and the steps that need to be adopted for reducing the risk of heart disease.
Furthermore, with ongoing developments in medical technology, rising burden of heart-related diseases, aging population, growing income, and shifting consumer expectations, it is anticipated that demand for endomyocardial biopsy will increase.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia endomyocardial biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Australia endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account